UBS AM
NRC icon

UBS AM’s NRC Health Common Stock NRC Stock Holding History

UBS AM’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306 Buy
+18
New +$306 ﹤0.01% 3752
2025
Q1 		– Sell
-38,565
Closed -$680K – 2683
2024
Q4 		$680K Buy
38,565
+1,148
+3% +$21.8K ﹤0.01% 2490
2024
Q3 		$855K Sell
37,417
-11,863
-24% -$268K ﹤0.01% 2464
2024
Q2 		$1.13M Buy
49,280
+18,237
+59% +$562K ﹤0.01% 2308
2024
Q1 		$1.23M Buy
31,043
+2,025
+7% +$80.1K ﹤0.01% 1912
2023
Q4 		$1.15M Buy
29,018
+915
+3% +$38.3K ﹤0.01% 1956
2023
Q3 		$1.25M Buy
28,103
+5,336
+23% +$233K ﹤0.01% 1838
2023
Q2 		$991K Hold
22,767
– – ﹤0.01% 2013
2023
Q1 		$991K Buy
22,767
+1,453
+7% +$64.2K ﹤0.01% 2013
2022
Q4 		$795K Buy
21,314
+490
+2% +$19K ﹤0.01% 1965
2022
Q3 		$829K Buy
20,824
+1,913
+10% +$70.8K ﹤0.01% 2079
2022
Q2 		$724K Hold
18,911
– – ﹤0.01% 2132
2022
Q1 		$750K Hold
18,911
– – ﹤0.01% 2281
2021
Q4 		$785K Buy
18,911
+293
+2% +$12.7K ﹤0.01% 2340
2021
Q3 		$785K Buy
18,618
+128
+0.7% +$6.45K ﹤0.01% 2286
2021
Q2 		$849K Buy
18,490
+7,194
+64% +$342K ﹤0.01% 2303
2021
Q1 		$529K Hold
11,296
– – ﹤0.01% 2368
2020
Q4 		$483K Hold
11,296
– – ﹤0.01% 2313
2020
Q3 		$556K Buy
+11,296
New +$625K ﹤0.01% 2098
2020
Q1 		– Sell
-3,333
Closed -$220K – 2505
2019
Q4 		$220K Buy
+3,333
New +$204K ﹤0.01% 2458

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS AM's NRC Position: Q1 2026 in Review

UBS AM opened a new position in NRC Health Common Stock (NRC) in Q1 2026: 18 shares worth $306. The stake represents ﹤0.01% of the portfolio and ranks #3752 among its holdings. This is a return to the name: UBS AM previously reported a position in NRC as recently as Q4 2024.

UBS AM first reported a position in NRC in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.25M in Q3 2023. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • UBS AM held 18 shares of NRC Health Common Stock worth $306 as of Q1 2026.
  • NRC Health Common Stock was a new UBS AM position in Q1 2026.
  • NRC Health Common Stock made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #3752 holding.
  • UBS AM first reported a position in NRC Health Common Stock in Q4 2019 and has held it in 20 quarters since.
  • UBS AM's NRC Health Common Stock position peaked at $1.25M in Q3 2023.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.